4//SEC Filing
Canaan XI L.P. 4
Accession 0000899243-21-049399
CIK 0001845337other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 4:40 PM ET
Size
7.8 KB
Accession
0000899243-21-049399
Insider Transaction Report
Form 4
Canaan Partners XI LLC
10% Owner
Transactions
- Other
Common Stock
2021-12-21−536,000→ 9,663,645 total
Canaan XI L.P.
10% Owner
Transactions
- Other
Common Stock
2021-12-21−536,000→ 9,663,645 total
Footnotes (2)
- [F1]On December 21, 2021, Canaan XI L.P. (the "Canaan Fund") distributed, for no consideration, 536,000 shares of Common Stock of the Issuer (the "Shares") to its limited partners and to Canaan Partners XI LLC ("Canaan XI"), the general partner of the Canaan Fund, representing each such partner's pro rata interest in the shares held by the Canaan Fund. On the same date, Canaan XI distributed, for no consideration, the Shares it received from the distribution to its members in an amount equal to each such member's pro rata interest in the Shares. The aforementioned distributions were made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended.
- [F2]These shares are held directly by the Canaan Fund. Canaan XI is the sole general partner of the Canaan Fund and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. Canaan XI disclaims Section 16 beneficial ownership of the securities held by the Canaan Fund, except to the extent of its pecuniary interest therein, if any.
Documents
Issuer
Day One Biopharmaceuticals, Inc.
CIK 0001845337
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001712417
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 4:40 PM ET
- Size
- 7.8 KB